Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR‐21‐3p/SMAD7 axis
Ting Dai,Shengkui Qiu,Xuesong Gao,Chengjin Zhao,Zhenming Ge,Yanmei Yang,Chong Tang,Shichun Feng
DOI: https://doi.org/10.1111/cas.16067
IF: 5.7
2024-01-30
Cancer Science
Abstract:In this study, we investigated the role of circWNK1, a specific circular RNA, in the development of gastric cancer (GC). Our findings revealed that circWNK1 expression is downregulated in GC and is associated with a poorer prognosis. Overexpressing circWNK1 inhibited GC cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT). Mechanistically, circWNK1 acted as a competitive endogenous RNA (ceRNA) for SMAD7 by sequestering miR‐21‐3p, thereby activating the TGF‐β signaling pathway. These results suggest that circWNK1 may serve as a potential biomarker and therapeutic target for GC. Gastric cancer (GC) is a highly aggressive malignancy with limited treatment options for advanced‐stage patients. Recent studies have highlighted the role of circular RNA (circRNA) as a novel regulator of cancer progression in various malignancies. However, the underlying mechanisms by which circRNA contributes to the development and progression of GC remain poorly understood. In this study, we utilized microarrays and real‐time quantitative polymerase chain reaction (qRT‐PCR) to identify and validate a downregulated circRNA, hsa_circ_0003251 (referred to as circWNK1), in paired GC and normal tissues. Through a series of in vitro and in vivo gain‐of‐function and loss‐of‐function assays, we demonstrated that circWNK1 exerts inhibitory effects on the proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) of GC cells. Additionally, we discovered that circWNK1 acts as a competitive endogenous RNA (ceRNA) for SMAD7 by sequestering miR‐21‐3p. Our findings were supported by comprehensive biological information analysis, as well as RNA pull‐down, luciferase reporter gene, and western blot assays. Notably, the downregulation of circWNK1 in GC cells resulted in reduced SMAD7 expression, subsequently activating the TGF‐β signaling pathway. Collectively, our study reveals that circWNK1 functions as a tumor suppressor in GC by regulating the miR‐21‐3p/SMAD7‐mediated TGF‐β signaling pathway. Furthermore, circWNK1 holds promise as a potential biomarker for the diagnosis and treatment of GC.
oncology